Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III confirmatory trial of intramyocardial HiCM-188 for severe heart failure
CTR20261882Phase 3Active
- Sponsor
- Help Therapeutics
- Start
- May 2026
- Modality
- iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of HiCM-188 in heart failure (HF), Ischemic congestive heart failure (ICM-HF), sponsored by Help Therapeutics. Started May 2026; status: active.
02
Drugs
HiCM-188
03
Conditions
heart failure (HF)Ischemic congestive heart failure (ICM-HF)
Beyond the preview
Go deeper on CTR20261882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261882.